Virbac SA

Paris Stock Exchange VIRP.PA

Virbac SA Shareholders' Equity for the year ending December 31, 2023: USD 993.71 M

Virbac SA Shareholders' Equity is USD 993.71 M for the year ending December 31, 2023, a 10.65% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Virbac SA Shareholders' Equity for the year ending December 31, 2022 was USD 898.04 M, a 8.82% change year over year.
Virbac SA Shareholders' Equity for the year ending December 31, 2021 was USD 825.23 M, a 8.79% change year over year.
Virbac SA Shareholders' Equity for the year ending December 31, 2020 was USD 758.55 M, a 30.54% change year over year.
Virbac SA Shareholders' Equity for the year ending December 31, 2019 was USD 581.07 M, a 10.30% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Paris Stock Exchange: VIRP.PA

Virbac SA

CEO	Mr. Habib Ramdani
IPO Date	July 7, 1992
Location	France
Headquarters	13e rue LID - BP 27
Employees	5,459
Sector	Consumers Staples
Industries Pet Food Agriculture Cosmetics Personal Care Pharmaceuticals

Description

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Key trends

Past 5 years